Hairy Cell Leukemia in Adults

We provide ongoing, compassionate care and monitoring for people with hairy cell leukemia. This is a rare, slow-growing cancer of infection-fighting white blood cells. Our specialists use sophisticated tests to diagnose this chronic disease and create a personalized treatment plan to manage it. Our team of oncologists, nurses, physical therapists, psychologists, and social workers can help enhance your wellbeing throughout treatment and recovery.

Clinical Trials and Research Studies

Phase 1

A Phase 1 Study Evaluating Safety Tolerability and Pharmacokinetics of Escalating Doses of AGS62P1 Given as Monotherapy in Subjects with Acute Myeloid Leukemia (AML)

Learn More

Phase 2

AALL1521: INCB 18424-269 A Phase 2 Study of the JAK1/JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High-Risk CRLF2-Rearranged and/or JAK Pathway-Mutant Acute Lymphoblastic Leukemia (ALL)

Learn More

Phase 3

AALL1331; Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND# 117467 NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)

Learn More

Phase 3

Treatment Of Patients Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) Or Localized B-Lineage Lymphoblastic Lymphoma

Learn More